Use of blockers and stimulators of prolactin secretion in persistent lactorrhea-amenorrhea syndrome.
D000236:Adenoma / Q000150:complications; D000568:Amenorrhea / Q000188:drug therapy* / Q000503:physiopathology; D002996:Clomiphene / Q000627:therapeutic use; D003277:Contraceptives, Oral, Combined; D005260:Female; D005687:Galactorrhea / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007775:Lactation Disorders / Q000188:drug therapy*; D007980:Levodopa / Q000627:therapeutic use; D008656:Mestranol / Q000627:therapeutic use; D009641:Norethynodrel / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000150:complications; D011247:Pregnancy; D011388:Prolactin / Q000378:metabolism*; D013577:Syndrome; D013973:Thyrotropin-Releasing Hormone
D003277:Contraceptives, Oral, Combined; D002996:Clomiphene; D007980:Levodopa; D013973:Thyrotropin-Releasing Hormone; C008124:Infecundin; D009641:Norethynodrel; D011388:Prolactin; D008656:Mestranol